Used in the detection and quantification of Golgi membrane protein 73 (GP73), this antibody serves as a critical tool in liver disease diagnostics, particularly for early detection of hepatocellular carcinoma (HCC). It enables immunohistochemistry, ELISA, and Western blot applications in clinical and research settings to monitor disease progression and evaluate therapeutic efficacy. Due to its high specificity, it supports the development of diagnostic kits and targeted therapies in oncology and hepatology.